Symbol="MIRM"
AssetType="Common Stock"
Name="Mirum Pharmaceuticals Inc"
Description="Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California."
CIK="1759425"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="950 TOWER LANE, SUITE 1050, FOSTER CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1012879000"
EBITDA="-113493000"
PERatio="None"
PEGRatio="None"
BookValue="3.843"
DividendPerShare="0"
DividendYield="0"
EPS="-3.53"
RevenuePerShareTTM="3.136"
ProfitMargin="-1.523"
OperatingMarginTTM="-1.023"
ReturnOnAssetsTTM="-0.257"
ReturnOnEquityTTM="-1.033"
RevenueTTM="115781000"
GrossProfitTTM="64688000"
DilutedEPSTTM="-3.53"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.145"
AnalystTargetPrice="51.8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="12.6"
PriceToBookRatio="3.955"
EVToRevenue="9.3"
EVToEBITDA="-16.18"
Beta="1.253"
num_52WeekHigh="30.55"
num_52WeekLow="17.32"
num_50DayMovingAverage="26.62"
num_200DayMovingAverage="23.59"
SharesOutstanding="38294100"
DividendDate="None"
ExDividendDate="None"
symbol="MIRM"
open="24.70"
high="26.69"
low="24.70"
price="26.45"
volume="927402.00"
latest_trading_day="2023-08-04"
previous_close="24.88"
change="1.57"
change_percent="6.3103%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="17"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="83"
Volume_recent_avg="575174"
Change_recent_avg="0.04"
Delta_recent_avg="1.09"
Variance_recent_avg="0.55"
Change_ratio_recent_avg="0.12"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="83"
Aroon_momentum_negative="17"
image_negative_thumbnail_id_1="497"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0108.jpeg"
image_negative_thumbnail_id_2="487"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0118.jpeg"
image_neutral_thumbnail_id_1="539"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="690"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0018.jpeg"
image_positive_thumbnail_id_2="612"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0096.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
